{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:01:57Z","timestamp":1747713717917,"version":"3.40.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-024-01650-w","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:34:03Z","timestamp":1735868043000},"page":"2405-2414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic Insights into Silymarin-Induced Apoptosis and Growth Inhibition in SPC212 Human Mesothelioma Cells"],"prefix":"10.1007","volume":"83","author":[{"given":"\u00d6zlem","family":"Tomsuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"Ka\u00e7ar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"1650_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-016-1267-x","volume":"16","author":"A Demiroglu-Zergeroglu","year":"2016","unstructured":"Demiroglu-Zergeroglu, A., Ergene, E., Ayvali, N., Kuete, V., & Sivas, H. (2016). Quercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells. BMC Complementary and Alternative Medicine, 16, 1\u20136.","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"1650_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.fct.2019.04.012","volume":"128","author":"S Dutta","year":"2019","unstructured":"Dutta, S., Mahalanobish, S., Saha, S., Ghosh, S., & Sil, P. C. (2019). Natural products: An upcoming therapeutic approach to cancer. Food and Chemical Toxicology, 128, 240\u2013255.","journal-title":"Food and Chemical Toxicology"},{"key":"1650_CR3","doi-asserted-by":"publisher","first-page":"36.","DOI":"10.1186\/s12906-018-2109-9","volume":"18","author":"V Kuete","year":"2018","unstructured":"Kuete, V., Ngnintedo, D., Fotso, G. W., Karaosmano\u011flu, O., Ngadjui, B. T., Keumedjio, F., Yeboah, S. O., Andrae-Marobela, K., & Sivas, H. (2018). Cytotoxicity of seputhecarpan D, thonningiol and 12 other phytochemicals from African flora towards human carcinoma cells. BMC Complementary and Alternative Medicine, 18, 36.","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"1650_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.fitote.2016.05.012","volume":"112","author":"SF Abouzid","year":"2016","unstructured":"Abouzid, S. F., Chen, S. N., McAlpine, J. B., Friesen, J. B., & Pauli, G. F. (2016). Silybum marianum pericarp yields enhanced silymarin products. Fitoterapia, 112, 136\u2013143.","journal-title":"Fitoterapia"},{"key":"1650_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.intimp.2017.06.030","volume":"50","author":"N Esmaeil","year":"2017","unstructured":"Esmaeil, N., Anaraki, S. B., Gharagozloo, M., & Moayedi, B. (2017). Silymarin impacts on immune system as an immunomodulator: One key for many locks. International Immunopharmacology, 50, 194\u2013201.","journal-title":"International Immunopharmacology"},{"key":"1650_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.fitote.2018.09.002","volume":"130","author":"C Giuliani","year":"2018","unstructured":"Giuliani, C., Tani, C., Maleci Bini, L., Fico, G., Colombo, R., & Martinelli, T. (2018). Localization of phenolic compounds in the fruits of Silybum marianum characterized by different silymarin chemotype and altered colour. Fitoterapia, 130, 210\u2013218.","journal-title":"Fitoterapia"},{"key":"1650_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ctim.2018.08.010","volume":"41","author":"A Hadi","year":"2018","unstructured":"Hadi, A., Pourmasoumi, M., Mohammadi, H., Symonds, M., & Miraghajani, M. (2018). The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Complementary Therapies in Medicine, 41, 311\u2013319.","journal-title":"Complementary Therapies in Medicine"},{"key":"1650_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.biopha.2018.03.140","volume":"102","author":"A Taleb","year":"2018","unstructured":"Taleb, A., Ahmad, K. A., Ihsan, A. U., Qu, J., Lin, N., Hezam, K., Koju, N., Hui, L., & Qilong, D. (2018). Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomedicine and Pharmacotherapy, 102, 689\u2013698.","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"1650_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5497\/wjp.v11.i3.27","volume":"11","author":"AY Onaolapo","year":"2022","unstructured":"Onaolapo, A. Y., Sulaiman, H., Olofinnade, A. T., & Onaolapo, O. J. (2022). Antidepressant-like potential of silymarin and silymarin-sertraline combination in mice: Highlighting effects on behaviour, oxidative stress, and neuroinflammation. World Journal of Pharmacology, 11, 27\u201347.","journal-title":"World Journal of Pharmacology"},{"key":"1650_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/1871524923666230823094403","volume":"23","author":"S Rostamian","year":"2023","unstructured":"Rostamian, S., Heidari-Soureshjani, S., & Sherwin, C. M. (2023). The therapeutic effect of Silymarin and Silibinin on depression and anxiety disorders and possible mechanism in the brain: A systematic review. Central Nervous System Agents in Medicinal Chemistry, 23, 86\u201394.","journal-title":"Central Nervous System Agents in Medicinal Chemistry"},{"key":"1650_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","volume":"6","author":"N Vargas-Mendoza","year":"2014","unstructured":"Vargas-Mendoza, N., Madrigal-Santill\u00e1n, E., Morales-Gonz\u00e1lez, \u00c1., Esquivel-Soto, J., Esquivel-Chirino, C., Garc\u00eda-Luna Y Gonz\u00e1lez-Rubio, M., Gayosso-de-Lucio, J. A., & Morales-Gonz\u00e1lez, J. A. (2014). Hepatoprotective effect of silymarin. World Journal of Hepatology, 6, 144.","journal-title":"World Journal of Hepatology"},{"key":"1650_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.sjbs.2020.10.063","volume":"28","author":"S Mukhtar","year":"2021","unstructured":"Mukhtar, S., Xiaoxiong, Z., Qamer, S., Saad, M., Mubarik, M. S., Mahmoud, A. H., & Mohammed, O. B. (2021). Hepatoprotective activity of silymarin encapsulation against hepatic damage in albino rats. Saudi Journal of Biological Sciences, 28, 717\u2013723.","journal-title":"Saudi Journal of Biological Sciences"},{"key":"1650_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.canlet.2008.03.053","volume":"269","author":"K Ramasamy","year":"2008","unstructured":"Ramasamy, K., & Agarwal, R. (2008). Multitargeted therapy of cancer by silymarin. Cancer Letters, 269, 352\u2013362.","journal-title":"Cancer Letters"},{"key":"1650_CR14","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3390\/molecules25092009","volume":"25","author":"D Delmas","year":"2020","unstructured":"Delmas, D., Xiao, J., Vejux, A., & Aires, V. (2020). Silymarin and cancer: A dual strategy in both in chemoprevention and chemosensitivity. Molecules, 25, 2009.","journal-title":"Molecules"},{"key":"1650_CR15","doi-asserted-by":"publisher","first-page":"2515690X2110688","DOI":"10.1177\/2515690X211068826","volume":"27","author":"T Koltai","year":"2022","unstructured":"Koltai, T., & Fliegel, L. (2022). Role of silymarin in cancer treatment: facts, hypotheses, and questions. Journal of Evidence-Based Integrative Medicine, 27, 2515690X211068826.","journal-title":"Journal of Evidence-Based Integrative Medicine"},{"key":"1650_CR16","first-page":"1166","volume":"25","author":"SA Emadi","year":"2022","unstructured":"Emadi, S. A., Rahbardar, M. G., Mehri, S., & Hosseinzadeh, H. (2022). A review of therapeutic potentials of milk thistle (Silybum marianum L.) and its main constituent, silymarin, on cancer, and their related patents. Iranian Journal of Basic Medical Sciences, 25, 1166.","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"1650_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02936-4","volume":"23","author":"M Singh","year":"2023","unstructured":"Singh, M., Kadhim, M. M., Turki Jalil, A., Oudah, S. K., Aminov, Z., Alsaikhan, F., Jawhar, Z. H., Ram\u00edrez-Coronel, A. A., & Farhood, B. (2023). A systematic review of the protective effects of silymarin\/silibinin against doxorubicin-induced cardiotoxicity. Cancer Cell International, 23, 88.","journal-title":"Cancer Cell International"},{"key":"1650_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.taap.2006.11.011","volume":"224","author":"M Kaur","year":"2007","unstructured":"Kaur, M., & Agarwal, R. (2007). Silymarin and epithelial cancer chemoprevention: How close we are to bedside? Toxicology and Applied Pharmacology, 224, 350\u2013359.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"1650_CR19","doi-asserted-by":"publisher","first-page":"101746","DOI":"10.1016\/j.toxrep.2024.101746","volume":"13","author":"S Srinivasan","year":"2024","unstructured":"Srinivasan, S., Mohanprasanth, A., Nadeem, A., & Saravanan, M. (2024). Exploring the anti-cancer and antimetastatic effect of silymarin against lung cancer. Toxicology Reports, 13, 101746.","journal-title":"Toxicology Reports"},{"key":"1650_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jep.2009.08.032","volume":"126","author":"S Kim","year":"2009","unstructured":"Kim, S., Kim, S. H., Hur, S. M., Lee, S. K., Kim, W. W., Kim, J. S., Kim, J. H., Choe, J. H., Nam, S. J., Lee, J. E., & Yang, J. H. (2009). Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells. Journal of Ethnopharmacology, 126, 252\u2013257.","journal-title":"Journal of Ethnopharmacology"},{"key":"1650_CR21","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.lfs.2007.09.008","volume":"81","author":"EA Soria","year":"2007","unstructured":"Soria, E. A., Eynard, A. R., Quiroga, P. L., & Bongiovanni, G. A. (2007). Differential effects of quercetin and silymarin on arsenite-induced cytotoxicity in two human breast adenocarcinoma cell lines. Life Sciences, 81, 1397\u20131402.","journal-title":"Life Sciences"},{"key":"1650_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.eujim.2015.10.012","volume":"7","author":"F Mohaghegh","year":"2015","unstructured":"Mohaghegh, F., Solhi, H., & Kazemifar, A. M. (2015). Silymarin (Milk Thistle) can revoke liver enzyme changes during chemotherapy of breast cancer with Taxanes. European Journal of Integrative Medicine, 7, 650\u2013652.","journal-title":"European Journal of Integrative Medicine"},{"key":"1650_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1254\/jphs.09171FP","volume":"111","author":"Y-y Jiang","year":"2009","unstructured":"Jiang, Y.-y, Wang, H.-j, Wang, J., Tashiro, S.-i, Onodera, S., & Ikejima, T. (2009). The protective effect of silibinin against mitomycin C-induced intrinsic apoptosis in human melanoma A375-S2 cells. Journal of Pharmacological Sciences, 111, 137\u2013146.","journal-title":"Journal of Pharmacological Sciences"},{"key":"1650_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.onc.1209146","volume":"25","author":"G Deep","year":"2006","unstructured":"Deep, G., Singh, R. P., Agarwal, C., Kroll, D. J., & Agarwal, R. (2006). Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: A comparison of flavanone silibinin with flavanolignan mixture silymarin. Oncogene, 25, 1053\u20131069.","journal-title":"Oncogene"},{"key":"1650_CR25","doi-asserted-by":"publisher","first-page":"7490","DOI":"10.1073\/pnas.96.13.7490","volume":"96","author":"X Zi","year":"2002","unstructured":"Zi, X., & Agarwal, R. (2002). Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention. Proceedings of the National Academy of Sciences, 96, 7490\u20137495.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1650_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/15230860260220166","volume":"4","author":"RP Singh","year":"2002","unstructured":"Singh, R. P., & Agarwal, R. (2002). Flavonoid antioxidant silymarin and skin cancer. Antioxidants & Redox Signaling, 4, 655\u2013663.","journal-title":"Antioxidants & Redox Signaling"},{"key":"1650_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tox.2006.07.021","volume":"227","author":"X Zhong","year":"2006","unstructured":"Zhong, X., Zhu, Y., Lu, Q., Zhang, J., Ge, Z., & Zheng, S. (2006). Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway. Toxicology, 227, 211\u2013216.","journal-title":"Toxicology"},{"key":"1650_CR28","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.biopha.2017.08.015","volume":"94","author":"L Khorsandi","year":"2017","unstructured":"Khorsandi, L., Saki, G., Bavarsad, N., & Mombeini, M. (2017). Silymarin induces a multi-targeted cell death process in the human colon cancer cell line HT-29. Biomedicine and Pharmacotherapy, 94, 890\u2013897.","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"1650_CR29","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1016\/j.fct.2012.06.007","volume":"50","author":"B Podder","year":"2012","unstructured":"Podder, B., Kim, Y. S., Zerin, T., & Song, H. Y. (2012). Antioxidant effect of silymarin on paraquat-induced human lung adenocarcinoma A549 cell line. Food and Chemical Toxicology, 50, 3206\u20133214.","journal-title":"Food and Chemical Toxicology"},{"key":"1650_CR30","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.colsurfb.2015.10.005","volume":"136","author":"MP Scavo","year":"2015","unstructured":"Scavo, M. P., Gentile, E., Wolfram, J., Gu, J., Barone, M., Evangelopoulos, M., Martinez, J. O., Liu, X., Celia, C., Tasciotti, E., Vilar, E., & Shen, H. (2015). Multistage vector delivery of sulindac and silymarin for prevention of colon cancer. Colloids and Surfaces B: Biointerfaces, 136, 694\u2013703.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"1650_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0022-4804(03)00229-4","volume":"113","author":"SH Yang","year":"2003","unstructured":"Yang, S. H., Lin, J. K., Chen, W. S., & Chiu, J. H. (2003). Anti-angiogenic effect of silymarin on colon cancer LoVo cell line. Journal of Surgical Research, 113, 133\u2013138.","journal-title":"Journal of Surgical Research"},{"key":"1650_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.fct.2008.12.024","volume":"47","author":"CH Chen","year":"2009","unstructured":"Chen, C. H., Huang, T. S., Wong, C. H., Hong, C. L., Tsai, Y. H., Liang, C. C., Lu, F. J., & Chang, W. H. (2009). Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food and Chemical Toxicology, 47, 638\u2013644.","journal-title":"Food and Chemical Toxicology"},{"key":"1650_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejphar.2014.09.019","volume":"743","author":"L Fan","year":"2014","unstructured":"Fan, L., Ma, Y., Liu, Y., Zheng, D., & Huang, G. (2014). Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells. European Journal of Pharmacology, 743, 79\u201388.","journal-title":"European Journal of Pharmacology"},{"key":"1650_CR34","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/1028602042000324862","volume":"7","author":"Q Huang","year":"2005","unstructured":"Huang, Q., Wu, L. J., Tashiro, S. I., Onodera, S., Li, L. H., & Ikejima, T. (2005). Silymarin augments human cervical cancer HeLa cell apoptosis via P38\/JNK MAPK pathways in serum-free medium. Journal of Asian Natural Products Research, 7, 701\u2013709.","journal-title":"Journal of Asian Natural Products Research"},{"key":"1650_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2184.2008.00581.x","volume":"42","author":"G Ramakrishnan","year":"2009","unstructured":"Ramakrishnan, G., Lo Muzio, L., Elinos-B\u00e1ez, C. M., Jagan, S., Augustine, T. A., Kamaraj, S., Anandakumar, P., & Devaki, T. (2009). Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Proliferation, 42, 229\u2013240.","journal-title":"Cell Proliferation"},{"key":"1650_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ptr.3618","volume":"26","author":"HC Yu","year":"2012","unstructured":"Yu, H. C., Chen, L. J., Cheng, K. C., Li, Y. X., Yeh, C. H., & Cheng, J. T. (2012). Silymarin inhibits cervical cancer cell through an increase of phosphatase and tensin homolog. Phytotherapy Research, 26, 709\u2013715.","journal-title":"Phytotherapy Research"},{"key":"1650_CR37","doi-asserted-by":"publisher","first-page":"105502","DOI":"10.1016\/j.jff.2023.105502","volume":"104","author":"M Koushki","year":"2023","unstructured":"Koushki, M., Yekta, R. F., & Amiri-Dashatan, N. (2023). Critical review of therapeutic potential of silymarin in cancer: A bioactive polyphenolic flavonoid. Journal of Functional Foods, 104, 105502.","journal-title":"Journal of Functional Foods"},{"key":"1650_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fonc.2018.00091","volume":"8","author":"M Rossini","year":"2018","unstructured":"Rossini, M., Rizzo, P., Bononi, I., Clementz, A., Ferrari, R., Martini, F., & Tognon, M. G. (2018). New perspectives on diagnosis and therapy of malignant pleural mesothelioma. Frontiers in Oncology, 8, 91.","journal-title":"Frontiers in Oncology"},{"key":"1650_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.lungcan.2018.11.034","volume":"127","author":"L Wu","year":"2019","unstructured":"Wu, L., Dell\u2019Anno, I., Lapidot, M., Sekido, Y., Chan, M. L., Kohno, M., Serre-Beinier, V., Felley-Bosco, E., & de Perrot, M. (2019). Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018). Lung Cancer, 127, 138\u2013145.","journal-title":"Lung Cancer"},{"key":"1650_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.freeradbiomed.2015.05.002","volume":"86","author":"SH Chew","year":"2015","unstructured":"Chew, S. H., & Toyokuni, S. (2015). Malignant mesothelioma as an oxidative stress-induced cancer: An update. Free Radical Biology and Medicine, 86, 166\u2013178.","journal-title":"Free Radical Biology and Medicine"},{"key":"1650_CR41","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ijc.2910410210","volume":"41","author":"RA Stahel","year":"1988","unstructured":"Stahel, R. A., O\u2019Hara, C. J., Weibel, R., & Martin, A. (1988). Monoclonal antibodies against mesothelial membrane antigen discriminate between malignant mesothelioma and lung adenocarcinoma. International Journal of Cancer, 41, 218\u2013223.","journal-title":"International Journal of Cancer"},{"key":"1650_CR42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1078\/094471103322004785","volume":"10","author":"H Zeytinoglu","year":"2003","unstructured":"Zeytinoglu, H., Incesu, Z., & Baser, K. H. C. (2003). Inhibition of DNA synthesis by carvacrol in mouse myoblast cells bearing a human N-ras oncogene. Phytomedicine, 10, 292\u2013299.","journal-title":"Phytomedicine"},{"key":"1650_CR43","unstructured":"Test, C. (2003) TEST METHOD PROTOCOL."},{"key":"1650_CR44","doi-asserted-by":"crossref","unstructured":"Fischer, A. H., Jacobson, K. A., Rose, J. & Zeller, R. (2008) Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harbor Protocols. 2008, pdb. prot4986.","DOI":"10.1101\/pdb.prot4986"},{"key":"1650_CR45","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1016\/j.fct.2010.09.001","volume":"48","author":"M Unlu","year":"2010","unstructured":"Unlu, M., Ergene, E., Unlu, G. V., Zeytinoglu, H. S., & Vural, N. (2010). Composition, antimicrobial activity and in vitro cytotoxicity of essential oil from Cinnamomum zeylanicum Blume (Lauraceae). Food and Chemical Toxicology, 48, 3274\u20133280.","journal-title":"Food and Chemical Toxicology"},{"key":"1650_CR46","doi-asserted-by":"publisher","first-page":"114292","DOI":"10.1016\/j.colsurfb.2024.114292","volume":"245","author":"A Ebrahimi","year":"2025","unstructured":"Ebrahimi, A., Ghorbanpoor, H., Apayd\u0131n, E., Cevizlidere, B. D., \u00d6zel, C., T\u00fcfek\u00e7io\u011flu, E., Ko\u00e7, Y., Topal, A. E., Tomsuk, \u00d6., & G\u00fcle\u00e7, K. (2025). Convenient rapid prototyping microphysiological niche for mimicking liver native basement membrane: Liver sinusoid on a chip. Colloids and Surfaces B: Biointerfaces, 245, 114292.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"1650_CR47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/10520299109109990","volume":"66","author":"BI Tarnowski","year":"1991","unstructured":"Tarnowski, B. I., Spinale, F. G., & Nicholson, J. H. (1991). DAPI as a useful stain for nuclear quantitation. Biotechnic and Histochemistry, 66, 297\u2013302.","journal-title":"Biotechnic and Histochemistry"},{"key":"1650_CR48","unstructured":"Wee, J. Z. (2021) Medicine, mesopotamia. Oxford Classical Dictionary."},{"key":"1650_CR49","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/biomedicines9101353","volume":"9","author":"WH Talib","year":"2021","unstructured":"Talib, W. H., Alsayed, A. R., Barakat, M., Abu-Taha, M. I., & Mahmod, A. I. (2021). Targeting drug chemo-resistance in cancer using natural products. Biomedicines, 9, 1353.","journal-title":"Biomedicines"},{"key":"1650_CR50","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.phytol.2019.04.003","volume":"31","author":"F Majolo","year":"2019","unstructured":"Majolo, F., de Oliveira Becker Delwing, L. K., Marmitt, D. J., Bustamante-Filho, I. C., & Goettert, M. I. (2019). Medicinal plants and bioactive natural compounds for cancer treatment: Important advances for drug discovery. Phytochemistry Letters, 31, 196\u2013207.","journal-title":"Phytochemistry Letters"},{"key":"1650_CR51","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.foodchem.2019.01.061","volume":"283","author":"M Pani\u0107","year":"2019","unstructured":"Pani\u0107, M., Radi\u0107 Stojkovi\u0107, M., Kralji\u0107, K., \u0160kevin, D., Radoj\u010di\u0107 Redovnikovi\u0107, I., Gaurina Sr\u010dek, V., & Rado\u0161evi\u0107, K. (2019). Ready-to-use green polyphenolic extracts from food by-products. Food Chemistry, 283, 628\u2013636.","journal-title":"Food Chemistry"},{"key":"1650_CR52","doi-asserted-by":"publisher","first-page":"9141","DOI":"10.3390\/ijms24119141","volume":"24","author":"MR Hatshan","year":"2023","unstructured":"Hatshan, M. R., Saquib, Q., Siddiqui, M. A., Faisal, M., Ahmad, J., Al-Khedhairy, A. A., Shaik, M. R., Khan, M., Wahab, R., & De Matteis, V. (2023). Effectiveness of nonfunctionalized graphene oxide nanolayers as nanomedicine against colon, cervical, and breast cancer cells. International Journal of Molecular Sciences, 24, 9141.","journal-title":"International Journal of Molecular Sciences"},{"key":"1650_CR53","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.tiv.2012.08.015","volume":"27","author":"R Clothier","year":"2013","unstructured":"Clothier, R., G\u00f3mez-Lech\u00f3n, M. J., Kinsner-Ovaskainen, A., Kopp-Schneider, A., O\u2019Connor, J. E., Prieto, P., & Stanzel, S. (2013). Comparative analysis of eight cytotoxicity assays evaluated within the ACuteTox Project. Toxicology in Vitro, 27, 1347\u20131356.","journal-title":"Toxicology in Vitro"},{"key":"1650_CR54","doi-asserted-by":"crossref","unstructured":"G\u00f6kta\u015f, H. G., Bacanl\u0131, M., Kutluk, B., Ba\u015faran, A. A. & Ba\u015faranNur\u015fen (2016) Cytotoxic activity of resveratrol in different cell lines evaluated by MTT and NRU assays. Hacettepe University.","DOI":"10.5505\/tjps.2016.40085"},{"key":"1650_CR55","doi-asserted-by":"publisher","first-page":"105384","DOI":"10.1016\/j.jff.2022.105384","volume":"100","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Yuan, A.-J., Wu, Y.-J., Wu, L.-M., & Zhang, L. (2023). Silymarin in cancer therapy: Mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations. Journal of Functional Foods, 100, 105384.","journal-title":"Journal of Functional Foods"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01650-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01650-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01650-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:03:29Z","timestamp":1747641809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01650-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1650"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01650-w","relation":{},"ISSN":["1559-0283"],"issn-type":[{"type":"electronic","value":"1559-0283"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"17 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not include any studies involving human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}